| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/10/2013 | CN102526033B Composition prepared from epigallocatechin gallate and mitomycin C and used for suppressing tumor cell proliferation |
| 07/10/2013 | CN102516366B Th1 cell factor immunoregulation polypeptide and application thereof |
| 07/10/2013 | CN102516363B CTL (Cytotoxic T Lymphocytes) epitope peptide from PL2L60 source and application thereof |
| 07/10/2013 | CN102516344B Compound with antitumor activity and preparation method and application thereof |
| 07/10/2013 | CN102417544B Ziyang selenium-rich green tea selenium-containing polysaccharide, and preparation method and application thereof |
| 07/10/2013 | CN102408426B Substituted aromatic urea compound and application as anticancer medicament thereof |
| 07/10/2013 | CN102397280B Application of 2 alpha-hydroxy protopanoxadiol medicine |
| 07/10/2013 | CN102382120B 11-(2, 4-dichlorophenyl) 12H-benzo[f]-furan [3, 4-b] chromene-10(11H)-ketone and synthetic method thereof |
| 07/10/2013 | CN102329376B Cyclo(phenylalanine-N-methylleucyl-leucyl-N-methylleucyl-leucyl), and synthesis method and application thereof |
| 07/10/2013 | CN102319439B Drug with magnetic microspheres, and use thereof |
| 07/10/2013 | CN102276556B Preparation method of 4-benzyl piperazi ethyliminumacyl (formimidoyl benzol) hydrazine compounds |
| 07/10/2013 | CN102240302B Chinese medicine composition of super gene active peptide |
| 07/10/2013 | CN102203118B Peptide antagonist of interleukin-15 activity |
| 07/10/2013 | CN102145174B Chondroitin sulfate nano-selenium and preparation method thereof |
| 07/10/2013 | CN102137929B Anti-CDH3 antibodies labeled with radioisotope label and uses thereof |
| 07/10/2013 | CN102079744B Deuterated achiral crizotinib and derivatives, preparation method and application thereof |
| 07/10/2013 | CN102070541B Letrozole I-type crystal and preparation method thereof |
| 07/10/2013 | CN102056628B Inorganic nanoparticles, preparation and uses thereof |
| 07/10/2013 | CN102030754B Non-viral vector, and preparation method and application thereof |
| 07/10/2013 | CN101935650B siRNA (Small interfering Ribonucleic Acid) molecule for interfering Survivin expression and application thereof |
| 07/10/2013 | CN101926770B Drug-loaded liposome and preparation method thereof |
| 07/10/2013 | CN101885689B Fat soluble dual-core cobalt (III) anti-tumor coordination compound and preparation method thereof |
| 07/10/2013 | CN101878216B Pyrimidine derivatives as protein kinase inhibitors |
| 07/10/2013 | CN101838261B Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 07/10/2013 | CN101816777B Novel Boanmycin composition and preparation method thereof |
| 07/10/2013 | CN101768080B Medicinal compound and medicinal use thereof |
| 07/10/2013 | CN101687841B Benzimidazole derivatives |
| 07/10/2013 | CN101643511B Fusion protein for inhibiting telomerase activity, preparation and application thereof |
| 07/10/2013 | CN101638383B Quinoline as well as pharmaceutical composition and use thereof |
| 07/10/2013 | CN101516385B Treatment of excessive neovascularization |
| 07/10/2013 | CN101375846B Ellagic acid supermolecule composition and preparation method |
| 07/10/2013 | CN101367794B Preparation method for quinazoline derivants and medical uses thereof |
| 07/10/2013 | CN101347521B Effective component of Clematis chinensis and preparation and use thereof |
| 07/10/2013 | CN101217954B Substituted oxazole derivatives and their use as tyrosine kinase inhibitors |
| 07/10/2013 | CN101072764B (-)-epigallocatechin gallate derivatives for inhibiting proteasome |
| 07/10/2013 | CN101052416B Improved adjuvant therapy of G250-expressing tumors |
| 07/09/2013 | US8481585 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 07/09/2013 | US8481572 Pharmaceutical compositions and methods for the treatment of cancer |
| 07/09/2013 | US8481542 Pyridazinyl derivatives as smo inhibitors |
| 07/09/2013 | US8481538 Heterocyclic inhibitors of c-Met and uses thereof |
| 07/09/2013 | US8481536 Benzotriazine inhibitors of kinases |
| 07/09/2013 | US8481513 3, 10, and 12a substituted tetracycline compounds |
| 07/09/2013 | US8481498 Pharmaceutical compositions and methods |
| 07/09/2013 | US8481497 Therapeutic agent for cancer, and method for treatment of cancer |
| 07/09/2013 | US8481091 Pharmaceutical compositions |
| 07/09/2013 | US8481075 Preparation and application of biodegradable-material-made microsphere vascular embolus containing liposome-encapsulated cytokines |
| 07/09/2013 | US8481044 Neprilysin inhibitors |
| 07/09/2013 | US8481042 Conjugates of pyrrolo[1,4]benzodiazepine dimers as anticancer agents |
| 07/09/2013 | US8481038 Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins |
| 07/09/2013 | US8481003 Anti-CD74 immunoconjugates and methods |
| 07/09/2013 | US8480995 Use of sodium selenosulfate for supplementing selenium and enhancing the therapeutic efficacy of chemotherapy agents, and a rapid process for preparing sodium selenosulfate |
| 07/09/2013 | CA2800260C Compositions and method for the treatment of multiple myeloma |
| 07/09/2013 | CA2761440C Fredericamycin derivatives |
| 07/09/2013 | CA2735932C Imidazo[1,5]naphthyridine compounds, their pharmaceutical use and compositions |
| 07/09/2013 | CA2608726C Inhibitors of vegf receptor and hgf receptor signaling |
| 07/09/2013 | CA2606077C Polymorphic and amorphous salt forms of squalamine dilactate |
| 07/09/2013 | CA2567694C Novel galactoside inhibitors of galectins |
| 07/09/2013 | CA2558600C A substituted-trialkyl amine compound with anti-viral activity based on antagonism against a chemokine receptor cxcr4 |
| 07/09/2013 | CA2494216C Use of dendritic cells (dcs) expressing interleukin 12 (il-12) |
| 07/09/2013 | CA2445593C Genetically modified yt cell line and use thereof |
| 07/09/2013 | CA2445565C Compositions and methods of double-targeting virus infections and cancer cells |
| 07/09/2013 | CA2408408C Modulators of tnf- alpha signaling |
| 07/09/2013 | CA2369413C Transmembrane protein expressed in prostate and other cancers |
| 07/09/2013 | CA2354188C Cancer cell vaccine |
| 07/06/2013 | CA2771564A1 Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensitivity and radiosensitivity in tumor or cancer cells |
| 07/04/2013 | WO2013102187A1 Methods and compositions for diagnosing and treating cancer |
| 07/04/2013 | WO2013102059A1 Pyrazolo [3, 4-d] pyrimidine and pyrrolo [2, 3-d] pyrimidine compounds as kinase inhibitors |
| 07/04/2013 | WO2013101954A1 3-phenyl-5-ureidoisothiazole-4-carboximide and 3-amino-5-phenylisothiazole derivatives as kinase inhibitors |
| 07/04/2013 | WO2013100772A1 The use of vitamin d analogues in combination with imatinib in therapy of non-small cell lung cancer |
| 07/04/2013 | WO2013100672A1 3,6-disubstituted indazole derivative having protein kinase inhibiting activity |
| 07/04/2013 | WO2013100632A1 THIENO[3,2-d]PYRIMIDINE DERIVATIVES HAVING INHIBITORY ACTIVITY FOR PROTEIN KINASES |
| 07/04/2013 | WO2013100631A1 Novel imidazopyridine derivatives as a tyrosine kinase inhibitor |
| 07/04/2013 | WO2013100580A1 Novel fusion protein binding to wnt |
| 07/04/2013 | WO2013100459A1 Composition comprising hair telogen- or catagen-inducing agent for preventing and alleviating alopecia caused by anticancer therapy |
| 07/04/2013 | WO2013098813A1 Endo180-targeted particles for selective delivery of therapeutic and diagnostic agents |
| 07/04/2013 | WO2013098339A1 Anti-tumor adjuvant therapy |
| 07/04/2013 | WO2013097873A1 Targeting cyclin b1 mrna with magnetic nanoparticles |
| 07/04/2013 | WO2013097773A1 Novel arylalkene derivatives and use thereof as selective estrogen receptor modulators |
| 07/04/2013 | WO2013097601A1 Bromodomain inhibitors |
| 07/04/2013 | WO2013097226A1 Fused tetra or penta-cyclic pyridophthalazinones as parp inhibitors |
| 07/04/2013 | WO2013097225A1 Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as parp inhibitors |
| 07/04/2013 | WO2013097224A1 Fused tricyclic compounds as raf kinase inhibitors |
| 07/04/2013 | WO2013097052A1 Bromodomain inhibitors |
| 07/04/2013 | WO2013064672A3 Oxazaphosphorines dosed one time for treating diseases |
| 07/04/2013 | WO2013059778A3 Antigen presenting cancer vaccine with gamma interferon |
| 07/04/2013 | WO2013055949A3 Pyrazol-3-ones that activate pro-apoptotic bax |
| 07/04/2013 | WO2013048211A3 Apoptosis-inducing composition comprising kaiso protein |
| 07/04/2013 | WO2013038195A3 Pharmaceutical nanoparticle compositions |
| 07/04/2013 | WO2013014538A3 Single-domain antibodies and graphene coated magnetic metal nanoparticles conjugate and methods for using the same |
| 07/04/2013 | WO2012145575A4 Therapy for leukemia |
| 07/04/2013 | WO2012003562A8 Antineoplastic pharmaceutical compositions containing substituted nitroimidazoles |
| 07/04/2013 | US20130172969 Heat patch for tumor |
| 07/04/2013 | US20130172656 Novel use of armillaridin for treating cancer |
| 07/04/2013 | US20130172407 Inhibition of Cancer Cell Proliferation Using Oleoylethanolamide |
| 07/04/2013 | US20130172336 4-anilinofuro[2,3-b]quinoline derivatives, their preparation processes, and pharmaceutical compositions comprising the same |
| 07/04/2013 | US20130172314 PYRAZOLO[3,4-d]PYRIMIDINE AND PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS AS KINASE INHIBITORS |
| 07/04/2013 | US20130171191 Compositions and Methods for Enhancing Dendritic Cell Resistance to Bacterial Infection and for Enhancing the Mobility of Dendritic Cells for Dendritic Cell-Based Immunotherapy |
| 07/04/2013 | US20130171174 Anti-human epidermal growth factor receptor antibody and uses thereof |
| 07/04/2013 | US20130171115 Cell-mediated gene therapy for cancer using mesenchymal stem cells expressing a suicide gene |
| 07/04/2013 | CA2858565A1 Methods of identifying and using mdm2 inhibitors |